Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis.
Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis.
复制标题
与癌症相关的IDH突变通过PI3K/AKT/MTORC1-HIF1α轴诱导GLUT1表达和葡萄糖代谢性疾病。
DOI:
10.1371/journal.pone.0257090
复制
发表时间:
2021
期刊:
影响因子:
3.7
通讯作者:
Ikenoue T
中科院分区:
文献类型:
--
作者:
Liu X;Yamaguchi K;Takane K;Zhu C;Hirata M;Hikiba Y;Maeda S;Furukawa Y;Ikenoue T
Isocitrate dehydrogenase 1 and 2 (IDH1/2) mutations and their key effector 2-hydroxyglutarate (2-HG) have been reported to promote oncogenesis in various human cancers. To elucidate molecular mechanism(s) associated with IDH1/2 mutations, we established mouse embryonic fibroblasts (MEF) cells and human colorectal cancer cells stably expressing cancer-associated IDH1R132C or IDH2R172S, and analyzed the change in metabolic characteristics of the these cells. We found that IDH1/2 mutants induced intracellular 2-HG accumulation and inhibited cell proliferation. Expression profile analysis by RNA-seq unveiled that glucose transporter 1 (Glut1) was induced by the IDH1/2 mutants or treatment with 2-HG in the MEF cells. Consistently, glucose uptake and lactate production were increased by the mutants, suggesting the deregulation of glucose metabolism. Furthermore, PI3K/Akt/mTOR pathway and Hif1α expression were involved in the up-regulation of Glut1. Together, these results suggest that Glut1 is a potential target regulated by cancer-associated IDH1/2 mutations.
登录
查看更多内容
影响因子:
56.9
作者:
Jaakkola, P;Mole, DR;Ratcliffe, PJ
通讯作者:
Ratcliffe, PJ
影响因子:
8
作者:
通讯作者:
--
影响因子:
13.8
作者:
Liberti MV;Locasale JW
通讯作者:
Locasale JW
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
16
作者:
Donohoe, Dallas R.;Collins, Leonard B.;Wali, Aminah;Bigler, Rebecca;Sun, Wei;Bultman, Scott J.
通讯作者:
Bultman, Scott J.